https://stock.noler.com/us/stock/fibrocell-science-inc https://stock.noler.com/us/stock/fibrocell-science-inc/accounts-payable https://stock.noler.com/us/stock/fibrocell-science-inc/accounts-receivable https://stock.noler.com/us/stock/fibrocell-science-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/fibrocell-science-inc/accrued-liabilities-current https://stock.noler.com/us/stock/fibrocell-science-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/fibrocell-science-inc/accrued-salaries-current https://stock.noler.com/us/stock/fibrocell-science-inc/accumulated-depreciation https://stock.noler.com/us/stock/fibrocell-science-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/fibrocell-science-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/fibrocell-science-inc/additional-paid-in-capital https://stock.noler.com/us/stock/fibrocell-science-inc/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/fibrocell-science-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/fibrocell-science-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/fibrocell-science-inc/allowance-for-doubtful-accounts-receivable-change https://stock.noler.com/us/stock/fibrocell-science-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/fibrocell-science-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/fibrocell-science-inc/amended-reports-10-k https://stock.noler.com/us/stock/fibrocell-science-inc/amended-reports-10-q https://stock.noler.com/us/stock/fibrocell-science-inc/amortization https://stock.noler.com/us/stock/fibrocell-science-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/fibrocell-science-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/fibrocell-science-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/fibrocell-science-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/fibrocell-science-inc/asset-impairment-charges https://stock.noler.com/us/stock/fibrocell-science-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/fibrocell-science-inc/basic-shares https://stock.noler.com/us/stock/fibrocell-science-inc/buybacks-form-sc-to-i https://stock.noler.com/us/stock/fibrocell-science-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/fibrocell-science-inc/capital-expenditures https://stock.noler.com/us/stock/fibrocell-science-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/fibrocell-science-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/fibrocell-science-inc/cash-and-equivalents https://stock.noler.com/us/stock/fibrocell-science-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/fibrocell-science-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/fibrocell-science-inc/cash-flow-breakdown https://stock.noler.com/us/stock/fibrocell-science-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/fibrocell-science-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/fibrocell-science-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/fibrocell-science-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/fibrocell-science-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/fibrocell-science-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/fibrocell-science-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/fibrocell-science-inc/common-stock-value https://stock.noler.com/us/stock/fibrocell-science-inc/contract-with-customer-asset-accumulated-allowance-for-credit-loss https://stock.noler.com/us/stock/fibrocell-science-inc/contract-with-customer-asset-gross https://stock.noler.com/us/stock/fibrocell-science-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/fibrocell-science-inc/contract-with-customer-asset-net-noncurrent https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation-due-after-fifth-year https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation-due-in-fourth-and-fifth-year https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation-due-in-second-and-third-year https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/fibrocell-science-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/fibrocell-science-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/fibrocell-science-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/fibrocell-science-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/fibrocell-science-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/fibrocell-science-inc/convertible-notes-payable https://stock.noler.com/us/stock/fibrocell-science-inc/convertible-preferred-dividends-net-of-tax https://stock.noler.com/us/stock/fibrocell-science-inc/cost-of-goods-sold https://stock.noler.com/us/stock/fibrocell-science-inc/cost-of-revenue https://stock.noler.com/us/stock/fibrocell-science-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/fibrocell-science-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/fibrocell-science-inc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/fibrocell-science-inc/current-assets https://stock.noler.com/us/stock/fibrocell-science-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/fibrocell-science-inc/current-liabilities https://stock.noler.com/us/stock/fibrocell-science-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/fibrocell-science-inc/debt-carrying-amount https://stock.noler.com/us/stock/fibrocell-science-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/fibrocell-science-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/fibrocell-science-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/fibrocell-science-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/fibrocell-science-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/fibrocell-science-inc/debt-longterm-and-shortterm-combined-amount https://stock.noler.com/us/stock/fibrocell-science-inc/debt-unamortized-discount https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-costs-current https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-rent-asset-net-current https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-rent-receivables-net-noncurrent https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-revenue https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-liabilities-financing-arrangements https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/fibrocell-science-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/fibrocell-science-inc/depreciation https://stock.noler.com/us/stock/fibrocell-science-inc/depreciation-and-amortization https://stock.noler.com/us/stock/fibrocell-science-inc/derivative-liabilities https://stock.noler.com/us/stock/fibrocell-science-inc/derivative-liabilities-current https://stock.noler.com/us/stock/fibrocell-science-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/fibrocell-science-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/fibrocell-science-inc/diluted-shares https://stock.noler.com/us/stock/fibrocell-science-inc/dilutive-securities https://stock.noler.com/us/stock/fibrocell-science-inc/dilutive-securities-effect-on-basic-earnings-per-share-other https://stock.noler.com/us/stock/fibrocell-science-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax https://stock.noler.com/us/stock/fibrocell-science-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax-per-basic-share https://stock.noler.com/us/stock/fibrocell-science-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/fibrocell-science-inc/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/fibrocell-science-inc/disposal-group-including-discontinued-operation-accounts-notes-and-loans-receivable-net https://stock.noler.com/us/stock/fibrocell-science-inc/disposal-group-including-discontinued-operation-accounts-payable https://stock.noler.com/us/stock/fibrocell-science-inc/disposal-group-including-discontinued-operation-accrued-liabilities https://stock.noler.com/us/stock/fibrocell-science-inc/disposal-group-including-discontinued-operation-inventory https://stock.noler.com/us/stock/fibrocell-science-inc/disposal-group-including-discontinued-operation-other-current-assets https://stock.noler.com/us/stock/fibrocell-science-inc/dividends-cash https://stock.noler.com/us/stock/fibrocell-science-inc/dividends-preferred-stock-cash https://stock.noler.com/us/stock/fibrocell-science-inc/dividends-preferred-stock-paidinkind https://stock.noler.com/us/stock/fibrocell-science-inc/due-to-related-parties-current https://stock.noler.com/us/stock/fibrocell-science-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/fibrocell-science-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/fibrocell-science-inc/effective-tax-rate https://stock.noler.com/us/stock/fibrocell-science-inc/eps https://stock.noler.com/us/stock/fibrocell-science-inc/eps-basic https://stock.noler.com/us/stock/fibrocell-science-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/fibrocell-science-inc/extinguishment-of-debt-gain-loss-income-tax https://stock.noler.com/us/stock/fibrocell-science-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/fibrocell-science-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/fibrocell-science-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/fibrocell-science-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/fibrocell-science-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/fibrocell-science-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/fibrocell-science-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/fibrocell-science-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/fibrocell-science-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/fibrocell-science-inc/financing-cash-flow https://stock.noler.com/us/stock/fibrocell-science-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/fibrocell-science-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/fibrocell-science-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/fibrocell-science-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/fibrocell-science-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/fibrocell-science-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/fibrocell-science-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/fibrocell-science-inc/form-d-other https://stock.noler.com/us/stock/fibrocell-science-inc/form-d-stocks https://stock.noler.com/us/stock/fibrocell-science-inc/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/fibrocell-science-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/fibrocell-science-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/fibrocell-science-inc/gross-profit https://stock.noler.com/us/stock/fibrocell-science-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/fibrocell-science-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-extraordinary-items-net-of-tax-per-basic-share https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/fibrocell-science-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/fibrocell-science-inc/income-tax https://stock.noler.com/us/stock/fibrocell-science-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/fibrocell-science-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/fibrocell-science-inc/income-tax-expense-benefit-discontinued-operations-extraordinary-items https://stock.noler.com/us/stock/fibrocell-science-inc/income-taxes-paid https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/fibrocell-science-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/fibrocell-science-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/fibrocell-science-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/fibrocell-science-inc/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/fibrocell-science-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/fibrocell-science-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/fibrocell-science-inc/indefinite-lived-intangible-assets-impairment-losses https://stock.noler.com/us/stock/fibrocell-science-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/fibrocell-science-inc/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/fibrocell-science-inc/insider-transactions-preferred https://stock.noler.com/us/stock/fibrocell-science-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/fibrocell-science-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/fibrocell-science-inc/insider-transactions-warrants https://stock.noler.com/us/stock/fibrocell-science-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/fibrocell-science-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/fibrocell-science-inc/interest-expense https://stock.noler.com/us/stock/fibrocell-science-inc/interest-income-expense-net https://stock.noler.com/us/stock/fibrocell-science-inc/interest-paid https://stock.noler.com/us/stock/fibrocell-science-inc/interest-payable-current https://stock.noler.com/us/stock/fibrocell-science-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/fibrocell-science-inc/inventory https://stock.noler.com/us/stock/fibrocell-science-inc/inventory-finished-goods https://stock.noler.com/us/stock/fibrocell-science-inc/inventory-gross https://stock.noler.com/us/stock/fibrocell-science-inc/inventory-raw-materials https://stock.noler.com/us/stock/fibrocell-science-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/fibrocell-science-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/fibrocell-science-inc/inventory-work-in-process https://stock.noler.com/us/stock/fibrocell-science-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/fibrocell-science-inc/inventory-write-down https://stock.noler.com/us/stock/fibrocell-science-inc/investing-cash-flow https://stock.noler.com/us/stock/fibrocell-science-inc/investment-income-interest https://stock.noler.com/us/stock/fibrocell-science-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/fibrocell-science-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/fibrocell-science-inc/lease-and-rental-expense https://stock.noler.com/us/stock/fibrocell-science-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/fibrocell-science-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/fibrocell-science-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/fibrocell-science-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/fibrocell-science-inc/long-term-debt https://stock.noler.com/us/stock/fibrocell-science-inc/marketing-expense https://stock.noler.com/us/stock/fibrocell-science-inc/minority-interest https://stock.noler.com/us/stock/fibrocell-science-inc/minority-interest-increase-from-stock-issuance https://stock.noler.com/us/stock/fibrocell-science-inc/net-change-in-cash https://stock.noler.com/us/stock/fibrocell-science-inc/net-income https://stock.noler.com/us/stock/fibrocell-science-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/fibrocell-science-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/fibrocell-science-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/fibrocell-science-inc/number-of-operating-segments https://stock.noler.com/us/stock/fibrocell-science-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/fibrocell-science-inc/oci-foreign-currency-transaction-and-translation-reclassification-adjustment-realized-upon-sale-or-liquidation-net-of-tax https://stock.noler.com/us/stock/fibrocell-science-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/fibrocell-science-inc/operating-cash-flow https://stock.noler.com/us/stock/fibrocell-science-inc/operating-expenses https://stock.noler.com/us/stock/fibrocell-science-inc/operating-income https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-assets https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-cost https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-expense https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-liability https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-liability-current https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-in-four-and-five-years https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-in-two-and-three-years https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/fibrocell-science-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/fibrocell-science-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/fibrocell-science-inc/other-noncurrent-assets https://stock.noler.com/us/stock/fibrocell-science-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/fibrocell-science-inc/other-nonoperating-income https://stock.noler.com/us/stock/fibrocell-science-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/fibrocell-science-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/fibrocell-science-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/fibrocell-science-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/fibrocell-science-inc/partners-capital-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/fibrocell-science-inc/payments-for-restructuring https://stock.noler.com/us/stock/fibrocell-science-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/fibrocell-science-inc/payments-of-dividends-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/fibrocell-science-inc/payments-of-financing-costs https://stock.noler.com/us/stock/fibrocell-science-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/fibrocell-science-inc/preferred-shares-facts https://stock.noler.com/us/stock/fibrocell-science-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/fibrocell-science-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/fibrocell-science-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/fibrocell-science-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/fibrocell-science-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/fibrocell-science-inc/preferred-stock-value-outstanding https://stock.noler.com/us/stock/fibrocell-science-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/fibrocell-science-inc/prepaid-expense-current https://stock.noler.com/us/stock/fibrocell-science-inc/pretax-income https://stock.noler.com/us/stock/fibrocell-science-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-divestiture-of-interest-in-subsidiaries-and-affiliates https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-issuance-of-redeemable-preferred-stock https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-payments-for-trading-securities https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-sale-of-trading-securities-heldforinvestment https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/fibrocell-science-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/fibrocell-science-inc/profit-loss https://stock.noler.com/us/stock/fibrocell-science-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/fibrocell-science-inc/property-plant-equipment https://stock.noler.com/us/stock/fibrocell-science-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/fibrocell-science-inc/public-float https://stock.noler.com/us/stock/fibrocell-science-inc/redeemable-preferred-stock-dividends https://stock.noler.com/us/stock/fibrocell-science-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/fibrocell-science-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/fibrocell-science-inc/research-and-development https://stock.noler.com/us/stock/fibrocell-science-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/fibrocell-science-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/fibrocell-science-inc/restructuring-charges https://stock.noler.com/us/stock/fibrocell-science-inc/restructuring-reserve https://stock.noler.com/us/stock/fibrocell-science-inc/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/fibrocell-science-inc/retained-earnings https://stock.noler.com/us/stock/fibrocell-science-inc/revenue https://stock.noler.com/us/stock/fibrocell-science-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/fibrocell-science-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/fibrocell-science-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/fibrocell-science-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/fibrocell-science-inc/sales-revenue-net https://stock.noler.com/us/stock/fibrocell-science-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/fibrocell-science-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-10-k https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-10-q https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-10ksb https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-10ksb40 https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-10qsb https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-15-12b https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-25 https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-25-nse https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-425 https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-8-k https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-certamx https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-certnas https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-certnys https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-ct-order https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-def-14a https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-def-14c https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-defa14a https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-defm14a https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-defr14a https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-ntn-10q https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-prem14a https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-regdex https://stock.noler.com/us/stock/fibrocell-science-inc/sec-filings-s-4 https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-pos-ex https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/fibrocell-science-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/fibrocell-science-inc/sga-expense https://stock.noler.com/us/stock/fibrocell-science-inc/shareholders-equity https://stock.noler.com/us/stock/fibrocell-science-inc/shares-authorized https://stock.noler.com/us/stock/fibrocell-science-inc/shares-issued https://stock.noler.com/us/stock/fibrocell-science-inc/short-term-debt https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/fibrocell-science-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/fibrocell-science-inc/stock-based-compensation https://stock.noler.com/us/stock/fibrocell-science-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/fibrocell-science-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/fibrocell-science-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/fibrocell-science-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/fibrocell-science-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/fibrocell-science-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/fibrocell-science-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/fibrocell-science-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/fibrocell-science-inc/stock-split-ratio https://stock.noler.com/us/stock/fibrocell-science-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/fibrocell-science-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/fibrocell-science-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/fibrocell-science-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/fibrocell-science-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/fibrocell-science-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/fibrocell-science-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/fibrocell-science-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/fibrocell-science-inc/tax-reconciliation-tax-settlements-domestic https://stock.noler.com/us/stock/fibrocell-science-inc/technology-services-costs https://stock.noler.com/us/stock/fibrocell-science-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/fibrocell-science-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/fibrocell-science-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/fibrocell-science-inc/total-assets https://stock.noler.com/us/stock/fibrocell-science-inc/total-liabilities https://stock.noler.com/us/stock/fibrocell-science-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/fibrocell-science-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/fibrocell-science-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/fibrocell-science-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/fibrocell-science-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/fibrocell-science-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/fibrocell-science-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/fibrocell-science-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/fibrocell-science-inc/workers-compensation-liability-current